{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T01:00:15Z","timestamp":1747184415483,"version":"3.40.5"},"reference-count":8,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T00:00:00Z","timestamp":1537315200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T00:00:00Z","timestamp":1537315200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Therapy"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1111\/dth.12629","type":"journal-article","created":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T12:02:55Z","timestamp":1537358575000},"page":"e12629","source":"Crossref","is-referenced-by-count":1,"title":["When side effect becomes the effect: Efficacy of capecitabine in refractory psoriasis"],"prefix":"10.1155","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0205-4590","authenticated-orcid":false,"given":"Yusuf","family":"Karakas","sequence":"first","affiliation":[{"name":"Medical Oncology Clinic; Hakkari State Hospital; Hakkari Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Secil","family":"Vural","sequence":"additional","affiliation":[{"name":"Dermatology Department; Ludwig Maximilian University; Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer","family":"Diker","sequence":"additional","affiliation":[{"name":"Medical Oncology Department; Hacettepe University Oncology Institute; Ankara Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer","family":"Dizdar","sequence":"additional","affiliation":[{"name":"Medical Oncology Department; Hacettepe University Oncology Institute; Ankara Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,9,19]]},"reference":[{"issue":"9997","key":"10.1111\/dth.12629-BIB0001|dth12629-cit-0001","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"10.1111\/dth.12629-BIB0002|dth12629-cit-0002","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/09546634.2010.507704","article-title":"Mechanisms of action of topical 5-fluorouracil: Review and implications for the treatment of dermatological disorders","volume":"23","author":"Ceilley","year":"2012","journal-title":"The Journal of Dermatological Treatment"},{"issue":"1","key":"10.1111\/dth.12629-BIB0003|dth12629-cit-0003","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.det.2014.09.008","article-title":"Current and future oral systemic therapies for psoriasis","volume":"33","author":"Kelly","year":"2015","journal-title":"Dermatologic Clinics"},{"issue":"4","key":"10.1111\/dth.12629-BIB0004|dth12629-cit-0004","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2174\/157016309789869092","article-title":"Current treatment of psoriasis with biologics","volume":"6","author":"Kunz","year":"2009","journal-title":"Current Drug Discovery Technologies"},{"issue":"8","key":"10.1111\/dth.12629-BIB0005|dth12629-cit-0005","first-page":"16399","article-title":"Psoriasis aggravation due to capecitabine in a colon cancer patient: A case report and literature review","volume":"9","author":"Ning","year":"2016","journal-title":"International Journal of Clinical and Experimental Medicine"},{"issue":"7","key":"10.1111\/dth.12629-BIB0006|dth12629-cit-0006","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1021\/cr900028p","article-title":"Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer","volume":"109","author":"Parker","year":"2009","journal-title":"Chemical Reviews"},{"issue":"4","key":"10.1111\/dth.12629-BIB0007|dth12629-cit-0007","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1046\/j.1365-2133.2002.493111.x","article-title":"Erosion of psoriatic plaques: An uncommon side-effect of neoadjuvant 5-fluorouracil treatment of colon cancer","volume":"147","author":"Wetzig","year":"2002","journal-title":"The British Journal of Dermatology"},{"key":"10.1111\/dth.12629-BIB0008|dth12629-cit-0008","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1111\/ajd.12714","article-title":"Psoriasis aggravation due to capecitabine: A case study and review of the literature","volume":"59","author":"Yap","year":"2017","journal-title":"Australasian Journal of Dermatology"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdth.12629","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/dth.12629\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:57:53Z","timestamp":1671818273000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.12629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,19]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"URL":"https:\/\/doi.org\/10.1111\/dth.12629","archive":["Portico"],"relation":{},"ISSN":["1396-0296"],"issn-type":[{"type":"print","value":"1396-0296"}],"subject":[],"published":{"date-parts":[[2018,9,19]]}}}